Dana-Farber

Boston, Massachusetts 02218

3 studies enrolling now · 22 studies all time

What they study most

Acute Lymphoblastic Leukemia, Advanced Cancers, Advanced Malignant Neoplasm, Advanced Solid Tumor, Bladder Cancer, Carcinoma, Squamous Cell, Cervical Cancer, Chronic Lung Disease, Chronic Lymphocytic Leukemia (CLL), Colorectal Cancer, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma

Studies at this site

• Metastatic Leiomyosarcoma Biomarker Protocol — Recruiting now
• A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma — Recruiting now
• Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients — Recruiting now
• A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors — Completed
• Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor — Running, not enrolling
• Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma — Completed
• High-Risk Skin Cancers With Atezolizumab Plus NT-I7 — Stopped early
• Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors — Stopped early
• A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors — Stopped early
• CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers — Completed
• A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma — Completed
• A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma — Stopped early
• AC220 for Children With Relapsed/Refractory ALL or AML — Completed
• Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma — Stopped early
• A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML — Completed
• A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL — Stopped early
• Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL — Stopped early
• A Study Of Panobinostat In Children With Refractory Hematologic Malignancies — Completed
• Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse — Completed
• A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck — Completed
• A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor — Completed